Lights and Shadows of Microbiota Modulation and Cardiovascular Risk in HIV Patients
Open Access
- 25 June 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (13), 6837
- https://doi.org/10.3390/ijerph18136837
Abstract
Human immunodeficiency virus (HIV) infection is associated with premature aging and the development of aging-related comorbidities, such as cardiovascular disease (CVD). Gut microbiota (GM) disturbance is involved in these comorbidities and there is currently interest in strategies focused on modulating GM composition and/or functionality. Scientific evidence based on well-designed clinical trials is needed to support the use of prebiotics, probiotics, symbiotics, and fecal transplantation (FT) to modify the GM and reduce the incidence of CVD in HIV-infected patients. We reviewed the data obtained from three clinical trials focused on prebiotics, 25 trials using probiotics, six using symbiotics, and four using FT. None of the trials investigated whether these compounds could reduce CVD in HIV patients. The huge variability observed in the type of compound as well as the dose and duration of administration makes it difficult to adopt general recommendations and raise serious questions about their application in clinical practice.Funding Information
- Consejería de Desarrollo Económico de La Rioja (DEI/27/2018)
This publication has 79 references indexed in Scilit:
- Human Gut Microbiota Changes Reveal the Progression of Glucose IntolerancePLOS ONE, 2013
- Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trialNutrition Journal, 2012
- Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infectionBMC Complementary and Alternative Medicine, 2012
- Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitusLipids in Health and Disease, 2012
- Effect of Micronutrient and Probiotic Fortified Yogurt on Immune-Function of Anti-Retroviral Therapy Naive HIV Patients
Nutrients, 2011
- Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trialMucosal Immunology, 2011
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV InfectionThe Journal of Infectious Diseases, 2011
- HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyAIDS, 2009
- Bacteroides: the Good, the Bad, and the Nitty-GrittyClinical Microbiology Reviews, 2007
- Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus DiseaseJournal of Clinical Endocrinology & Metabolism, 2007